Westwood Management Corp Dexcom Inc Transaction History

Westwood Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$78.0 - $104.5 $6.08 Million - $8.15 Million	-77,960 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$95.51 - $112.95 $66,857 - $79,065	-700 Reduced 0.89%	77,960 $32.1 Million
Q2 2020 Jul 27, 2020	SELL	$62.68 - $105.34 $376,080 - $632,040	-6,000 Reduced 7.09%	78,660 $31.9 Million
Q1 2020 Apr 27, 2020	SELL	$47.79 - $75.63 $540,027 - $854,619	-11,300 Reduced 11.78%	84,660 $22.8 Million
Q4 2019 Jan 24, 2020	SELL	$36.62 - $57.29 $40,282 - $63,019	-1,100 Reduced 1.13%	95,960 $21 Million
Q3 2019 Oct 25, 2019	SELL	$35.53 - $43.8 $31,977 - $39,420	-900 Reduced 0.92%	97,060 $14.5 Million
Q2 2019 Jul 25, 2019	SELL	$27.84 - $38.92 $116,371 - $162,685	-4,180 Reduced 4.09%	97,960 $14.7 Million
Q1 2019 Apr 25, 2019	SELL	$28.07 - $38.18 $28,070 - $38,180	-1,000 Reduced 0.97%	102,140 $12.2 Million
Q4 2018 Jan 25, 2019	BUY	$26.99 - $37.37 $67,475 - $93,425	2,500 Added 2.48%	103,140 $12.4 Million
Q3 2018 Oct 26, 2018	BUY	$23.35 - $36.72 $1.84 Million - $2.89 Million	78,700 Added 358.71%	100,640 $14.4 Million
Q2 2018 Jul 24, 2018	BUY	$17.54 - $25.22 $384,827 - $553,326	21,940 New	21,940 $2.08 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Westwood Management Corp , based on Form 13F filings with the SEC.

Stay updated on Westwood Management Corp with notifications on news.